# South Korean Pitavastatin Heart Failure Study

> **NCT00701285** · PHASE4 · COMPLETED · sponsor: **JW Pharmaceutical** · enrollment: 70 (estimated)

## Conditions studied

- Chronic Heart Failure

## Interventions

- **DRUG:** pitavastatin
- **DRUG:** pravastatin

## Key facts

- **NCT ID:** NCT00701285
- **Lead sponsor:** JW Pharmaceutical
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-07
- **Primary completion:** 2013-05
- **Final completion:** 2014-05
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2014-05-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00701285

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00701285, "South Korean Pitavastatin Heart Failure Study". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00701285. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*